DLTH stock surged +39% over the past 30 days, driven primarily by a strong Q4 earnings beat on March 19 with net income of $7.8 million and gross margin expansion to 53.0%. Over the past quarter, the stock rose approximately +40%, reflecting improved profitability, inventory reduction, and positive guidance despite sales declines.

CRGO stock surged +33% over the past 30 days, rebounding from March lows near $1.17 amid positive analyst sentiment and platform expansions. Over the past quarter, the stock declined -23%, pressured by weaker-than-expected 2026 revenue guidance and sector headwinds.

BABA stock declined approximately -6% over the past 30 days, driven primarily by a disappointing earnings report featuring a sharp drop in net profit despite AI advancements. Over the past quarter, the stock fell around -19%, reflecting broader pressures from heavy investments in cloud and AI, weak consumer spending in China, and macroeconomic headwinds.

Palantir's Artificial Intelligence Platform (AIP) positions it for explosive U.S. commercial revenue growth exceeding $3.144 billion in FY 2026, implying at least 115% year-over-year expansion. Consensus among 29 analysts rates PLTR as a Moderate Buy, with an average 12-month price target of $197.77, suggesting over 33% upside from recent levels.

BAC shares have shown resilience in recent trading sessions amid macroeconomic warnings, trading around $49 with a year-to-date gain of approximately 9%. Analyst consensus remains bullish with an average price target near $60, supported by upgrades from HSBC and others highlighting capital return potential.

Shares of Aehr Test Systems (AEHR) surged approximately +16% on Monday, April 6, 2026, during active trading session. The primary catalyst is pre-earnings positioning ahead of the company's Q3 fiscal 2026 results scheduled for Tuesday, April 7, after market close.

Seagate Technology (STX) shares are surging approximately +8% in early Monday trading, recovering sharply from the tariff-driven market turbulence that weighed on equities late last week. The rebound follows reports of potential electronics and storage product tariff relief, easing fears of supply chain cost pressures on HDDs manufactured predominantly in Asia.

Swarmer, Inc. (NASDAQ: SWMR) is trading down approximately 27% in Monday's session, falling from its prior closing price of $66.48 to approximately $48.53. The decline follows an extended post-IPO speculative rally that took the stock from a $5 IPO price to nearly $69 in under three weeks — a gain of over 1,270%.

Shares of Viridian Therapeutics (VRDN) are declining approximately 13% in Monday's active trading session, approaching the $16.39 area from a prior close of approximately $18.84 on April 3, 2026. The move represents a continuation of the sharp post-REVEAL-1 selloff that began on March 30, 2026, when the stock fell over 32% following the release of subcutaneous elegrobart Phase 3 trial data.

PG stock declined approximately -10% over the last 30 days amid softer consumer demand in categories like baby care and grooming, alongside increased promotional activity. Over the past quarter, the stock is up +2%, reflecting resilience from Q2 earnings beat on EPS despite revenue miss and guidance maintenance.

Shares of Lightwave Logic, Inc. (LWLG) are surging approximately +15.00% in premarket trading on Monday, April 6, 2026, extending a powerful multi-week rally. The primary catalyst is the company's newly announced integration of its electro-optic polymer modulator platform into the GDSFactory design kit, enabling direct access through GlobalFoundries' advanced silicon photonics platform for high-bandwidth data center applications.

Shares of Soleno Therapeutics surged approximately +32% in premarket trading on Monday, April 7, 2026, with trading halted shortly after the opening due to the sharp spike. The primary catalyst is a confirmed acquisition agreement: Neurocrine Biosciences agreed to acquire Soleno Therapeutics in a deal valued at approximately $2.9 billion.

AESI shares are indicated down approximately 11% in Monday premarket trading, falling from a prior close of approximately $13.44 to around $11.96. Primary catalyst: Atlas Energy Solutions issued an operational update slashing Q1 2026 adjusted EBITDA guidance to a range of $26M–$30M, down sharply from $36.7M reported in Q4 2025.

Chevron stands out as one of the world's leading integrated energy companies, with a diversified portfolio that covers upstream exploration and production, midstream transportation, downstream refining, and emerging lower-carbon ventures. From my perspective, its competitive advantages are clear: a vast global footprint across North America, South America, Europe, Africa, Asia, and Australia helps mitigate risks through geographic diversity.

AbbVie Inc. (ABBV) stands out as a research-based biopharmaceutical company dedicated to developing and commercializing therapies across immunology, oncology, neuroscience, eye care, and aesthetics. At its core, the company's business model relies on a diversified portfolio of blockbuster drugs, with immunology standouts like Skyrizi (risankizumab) and Rinvoq (upadacitinib) fueling growth following the Humira patent expiration.

I've been keeping a close eye on Netflix (NFLX) stock as it navigates some turbulent sessions lately. The shares have pulled back from multi-month lows and are holding steady within their yearly range, showing real strength compared to those earlier dips. This recovery feels driven by smart pricing moves in the U.S. and encouraging notes from analysts.

I've been keeping a close eye on Oracle Corporation (ORCL) as it navigates some choppy waters lately. The stock has been trading near the lower end of its recent range, pulled back by broader tech sector pressures and company-specific dynamics around AI investments. Heightened scrutiny on capital expenditures and workforce adjustments has weighed on sentiment, but the underlying fundamentals look solid to me.

🔥 TAX DAY SALE — 75% OFF till April 15! Access AI Robots, Signals & Market Tools

The U.S. small-cap universe is on fire — and not just because the Russell 2000 (IWM) just posted the longest 14-session winning streak against the S&P 500 since 1996. While large-cap indices like the SPY fell -7.81% this quarter and QQQ shed -7.61%, IWM actually gained +0.36% in the week of March 23–27 alone.

One thing that stands out about KMI is its vast energy infrastructure network across North America—about 70,000 miles of natural gas pipelines that transport roughly 40% of U.S. production. This scale creates a real competitive advantage, allowing efficient links from key basins like the Permian, Haynesville, and Marcellus to high-demand areas such as LNG export terminals and power plants. With around 70% of its cash flows coming from take-or-pay or hedged contracts, the company enjoys revenue predictability that shields it from volume swings, unlike some peers more exposed to commodity prices.